全身疾病与非青光眼眼压均值、峰值及变异性的长期关系
本研究基于年龄相关眼病研究(AREDS)随机临床试验数据,对3909例无青光眼诊断或治疗的老年参与者进行长达12年的年度眼压与全身疾病数据分析。结果显示糖尿病、肥胖及收缩期高血压与眼压升高显著相关,全身β受体阻滞剂使用呈反向关联,且全身疾病还影响眼压峰值与变异性。
要点
- 糖尿病、肥胖、收缩期高血压与眼压升高显著相关
- 全身β受体阻滞剂使用与眼压呈反向关联
- 全身疾病不仅影响眼压均值,还影响峰值与变异性
核心结论
- 多种全身疾病与眼压相关,且影响眼压均值之外的峰值与变异性等参数。
- 这些人群层面趋势提示眼压控制中存在潜在可干预因素,在肥胖与糖尿病患病率上升背景下尤为重要。
研究设计与样本
- AREDS随机临床试验数据的二次分析,该试验为高剂量抗氧化剂随机临床试验。
- 纳入3909例无青光眼诊断或治疗报告的老年参与者,提供长达12年的年度眼压与全身疾病数据。
主要发现
- 单变量分析发现众多全身疾病因素与眼压均值、峰值及变异性相关。
- 纵向校正模型显示糖尿病、肥胖及收缩期高血压与眼压升高显著相关。
- 纵向校正模型显示全身β受体阻滞剂使用与眼压呈反向关联。
临床怎么用
- 在眼压管理中可关注糖尿病、肥胖、收缩期高血压等全身疾病及全身β受体阻滞剂使用情况。
- 解读眼压时应同时考虑均值、峰值与变异性,而非仅关注均值。
局限性
- 原文未报告具体效应量、置信区间及P值,相关结论仅限眼压背景解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Elevated intraocular pressure (IOP) is a well-known risk factor in glaucoma development and progression. As most glaucoma risk factors are not modifiable, IOP remains the sole focus of medical and surgical therapy. Identifying modifiable factors and their effects on IOP, such as systemic diseases, is therefore of interest. The objective is to assess the long-term, longitudinal relationship between systemic diseases and IOP mean, peak, and variability, including diabetes, hypertension, body mass index (BMI), and smoking status. DESIGN: Secondary analysis of randomized clinical trial data. METHODS: Longitudinal IOP and systemic disease data from the Age-Related Eye Disease Study (AREDS), a randomized clinical trial of high-dose antioxidants, was analyzed. STUDY POPULATION: A total of 3909 older participants without a reported diagnosis of glaucoma or glaucoma treatment during AREDS with up to 12 years of annual IOP and systemic disease data. MAIN OUTCOME MEASURES: Independent systemic disease risk factors associated with IOP. RESULTS: Univariate analysis identified numerous systemic disease factors associated with IOP mean, peak, and variability. Longitudinal adjusted models identified diabetes, obesity, and systolic hypertension as significantly associated with increased IOP, while systemic beta-blocker use was inversely associated. CONCLUSIONS: Results demonstrate a relationship between multiple systemic diseases and IOP; moreover, they demonstrate that systemic diseases influence additional parameters beyond mean IOP, such as IOP peak and variability. Although only to be taken within the context of IOP, these population-level trends reveal potentially modifiable factors in IOP control, and are particularly important in the context of increasing obesity and diabetes prevalence rates in American adults.
引用
- Dikopf MS, Vajaranant TS, Joslin CE, et al. Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes. Am J Ophthalmol. 2018. PMID: 29981739. doi:10.1016/j.ajo.2018.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。